Anixa Biosciences (ANIX) Return on Assets [ROA] (2011 - 2026)
Anixa Biosciences' Return on Assets [ROA] came in at -67.89% for fiscal Q3 2026 (quarter ended Jul 31, 2026), down 3.09 percentage points from -64.80% a year earlier and down 0.99 percentage points from the prior quarter.
Anixa Biosciences (ANIX) Return on Assets [ROA] (2011 - 2026) Analysis & Trends
For FY2025 (ended Oct 31, 2025), Anixa Biosciences' Return on Assets [ROA] was -58.55%, down 4.64 percentage points from FY2024.
- Return on Assets [ROA] carries a five-year change of +69.64 percentage points (FY2020 to FY2025).
- Going back by fiscal year, Return on Assets [ROA] was -53.90% in FY2024 (-18.40 pp), -35.51% in FY2023 (+5.81 pp), -41.31% in FY2022 (+16.13 pp) and -57.44% in FY2021 (+70.74 pp).
- The fiscal Q3 2026 figure represents the lowest quarterly Return on Assets [ROA] since fiscal Q2 2025.
- Year-over-year, Return on Assets [ROA] increased in 1 of the last seven quarters, with an average year-over-year change of -11.65 percentage points.
- The fastest year-over-year change in Return on Assets [ROA] over five years came in fiscal Q4 2021 (a gain of 71.47 percentage points), and the weakest in fiscal Q2 2025 (a drop of 21.09 percentage points).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 10.47% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 4.65% |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.45% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 28.37% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 9.10% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 9.29% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -6.13% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 2.14% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 16.34% |
| 10 | Anixa Biosciences | 101.33 Mn | 100.06 Mn | - | -67.89% |
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | -67.89% |
| Apr 30, 2026 | -66.90% |
| Oct 31, 2025 | -65.39% |
| Jul 31, 2025 | -64.80% |
| Apr 30, 2025 | -68.30% |
| Jan 31, 2025 | -62.33% |
| Oct 31, 2024 | -57.07% |
| Jul 31, 2024 | -52.92% |
| Apr 30, 2024 | -47.21% |
| Jan 31, 2024 | -42.70% |
| Oct 31, 2023 | -38.12% |
| Jul 31, 2023 | -39.64% |
| Apr 30, 2023 | -39.23% |
| Jan 31, 2023 | -41.71% |
| Oct 31, 2022 | -43.73% |
| Jul 31, 2022 | -43.80% |
| Apr 30, 2022 | -46.82% |
| Jan 31, 2022 | -41.33% |
| Oct 31, 2021 | -35.81% |
| Jul 31, 2021 | -29.90% |
Anixa Biosciences Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=ANIX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "ANIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=ANIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();